type here...

CATEGORIES

Patient Zone

LATEST

1...678...59Page 7 of 59

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Eight Early Signs of Heart Trouble You Shouldn’t Ignore

Medika Life -
Recognizing Heart Attack symptoms early on can save your life or the life of someone close to you. Some are obvious and others can mimic different conditions.

Clinic Notes: I Didn’t Expect to Speak Japanese Today

Michael Hunter, MD -
He came in wearing a loose hospital gown, but he carried himself like a man who had once walked freely through the world. When I...

Roby Mitchell (Dr. Fitt) on Medika’s Quack Scale

Medika Life -
Dr Joseph Mercola scores 5 out of 5 on Medika's Quack Scale. Mercola is the ultimate digital Quack cum snake oil salesman.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories